Design and optimization of DPC-crosslinked HPβCD nanosponges for entrectinib oral delivery: formulation, characterization, and pharmacokinetic studies

Abstract Background In advanced or metastatic cancers characterized by specific genetic alterations, heightened growth and resistance to conventional therapies are common. Targeted treatments like entrectinib (ENT) precisely inhibit aberrant signaling pathways, potentially enhancing outcomes. The ob...

Cijeli opis

Bibliografski detalji
Glavni autori: Konda Sri Chaya Reddy, Darna Bhikshapathi
Format: Članak
Jezik:English
Izdano: SpringerOpen 2024-08-01
Serija:Future Journal of Pharmaceutical Sciences
Teme:
Online pristup:https://doi.org/10.1186/s43094-024-00680-8